nRichDX Inc, based in Irvine, CA is an emerging leader in the liquid biopsy sample prep market, delivering up to 10X more target material (ctDNA, CTCs, exosomes, etc.) than existing sample prep systems for molecular testing.
The patented Revolution™ System is the first high-yield, IVD-labeled liquid biopsy sample prep platform that can process volumes from 1 mL-50 mL and offers a single solution for multiple specimen types and targets. nRichDX solves one of precision medicine’s greatest problems - - inaccurate diagnostic results for up to 50% of liquid biopsy-based molecular diagnostic tests (NGS, PCR, Micro Array, etc.) due to a lack of target material.
The Revolution platform greatly enhances test sensitivity and enables high confidence test results that promote earlier detection, monitoring, timely treatment and optimal patient outcomes.
